Dr. Emilio Emini, Ex-Chief Executive Officer of the Bill and Melinda Gates Medical Research Institute.
Dr. Mark Prausnitz, Regent' Professor, J. Erskine Love Jr. Chair in Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery, Georgia Institute of Technology.
Dr. James Birchall, Professor of Pharmaceutical Sciences and Deputy Head of School of Pharmacy and Pharmaceutical Sciences, Cardiff University.
Dr. Paul Griffin, Director of Infectious Diseases at Mater Health Services in Brisbane and Associate Professor of Medicine at the University of Queensland Medical School.
Dr. Deborah Pascoe, Senior Vice President Pipeline Development, Vaxxas.
Professor Anthony Cunningham, Director, Centre for Virus Research, Professor and Vaccine Theme Leader, The Westmead Institute for Medical Research / University of Sydney / Australian Centre for HIV and Hepatitis Virology Research (ACH4).
Professor Anthony Cunningham, Director, Centre for Virus Research, Professor and Vaccine Theme Leader, The Westmead Institute for Medical Research / University of Sydney / Australian Centre for HIV and Hepatitis Virology Research (ACH4).
Courtney Jarrahian, Global Program Leader for PATH’s Medical Devices and Health Technologies Program.
Dr. Chris McMillan, Virologist at The University of Queensland.
Dr. Rochelle Chaiken, Chief Medical Officer at Vaxxas.
Dr. Kristen Earle, Senior Program Officer at the Gates Foundation.
Collrane Frivold, Technical Officer for PATH’s Medical Devices and Health Technologies Global Program.
Dr. Chris McMillan, Virologist at The University of Queensland.
Dr. Rochelle Chaiken, Chief Medical Officer at Vaxxas.
Dr. Kristen Earle, Senior Program Officer at the Gates Foundation.
Collrane Frivold, Technical Officer for PATH’s Medical Devices and Health Technologies Global Program.